S 1186119th CongressIntroduced

Lower Drug Costs for Families Act

Introduced: Oct 28, 2025

Standard Summary

Comprehensive overview in 1-2 paragraphs

S. 1186 amends Medicare Part B and Part D to apply inflation rebates to drugs furnished in the commercial market and changes the base year for rebate calculations, effective Jan 1 2026.

Key Points

1Inflation rebates are extended to Part B drugs furnished in the commercial market.
2The base year for rebate calculations is changed from 2021 to 2016.
3Similar changes are applied to Part D drugs, including adjustments to billing units and excluded units.
4The amendments take effect on January 1 2026 for both Part B and Part D.
5The goal is to reduce prescription drug costs for Medicare beneficiaries.

Impact Areas

Medicare Part B and Part D beneficiariesDrug manufacturers and pharmaciesThe Medicare program and its budgetBeneficiaries’ out‑of‑pocket drug costs

Generated by openai/gpt-oss-20b:free on Nov 20, 2025